BriaCell Therapeutics (8BT) Cash flow

0 Followers

BriaCell Therapeutics Cash Flow

DE:8BT's free cash flow for Q3 2026 was C$-7.14M. For the 2026 fiscal year, DE:8BT's free cash flow was decreased by C$-3.93M and operating cash flow was C$-7.02M. See a summary of the company’s cash flow.

Cash Flow	Jul 25	Jul 24	Jul 23	Jul 22	Jul 21
Operating Cash Flow	$ -28.51M	$ -24.13M	$ -23.74M	$ -12.48M	$ -7.75M
Investing Cash Flow	$ -7.74M	$ -681.80K	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 46.00M	$ 4.42M	$ 3.95M	$ -3.74M	$ 65.00M
End Cash Position	$ 10.53M	$ 862.09K	$ 21.25M	$ 41.04M	$ 57.27M
Free Cash Flow	$ -28.51M	$ -24.58M	$ -23.74M	$ -12.48M	$ -7.75M